142 related articles for article (PubMed ID: 19922503)
1. XAF1 as a prognostic biomarker and therapeutic target in pancreatic cancer.
Huang J; Yao WY; Zhu Q; Tu SP; Yuan F; Wang HF; Zhang YP; Yuan YZ
Cancer Sci; 2010 Feb; 101(2):559-67. PubMed ID: 19922503
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma.
Zhu LM; Shi DM; Dai Q; Cheng XJ; Yao WY; Sun PH; Ding Y; Qiao MM; Wu YL; Jiang SH; Tu SP
Oncotarget; 2014 Jul; 5(14):5403-15. PubMed ID: 24980821
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
Augello C; Caruso L; Maggioni M; Donadon M; Montorsi M; Santambrogio R; Torzilli G; Vaira V; Pellegrini C; Roncalli M; Coggi G; Bosari S
BMC Cancer; 2009 Apr; 9():125. PubMed ID: 19397802
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression.
Tu SP; Sun YW; Cui JT; Zou B; Lin MC; Gu Q; Jiang SH; Kung HF; Korneluk RG; Wong BC
Cancer; 2010 Mar; 116(5):1252-63. PubMed ID: 20082449
[TBL] [Abstract][Full Text] [Related]
5. Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
Arora V; Cheung HH; Plenchette S; Micali OC; Liston P; Korneluk RG
J Biol Chem; 2007 Sep; 282(36):26202-9. PubMed ID: 17613533
[TBL] [Abstract][Full Text] [Related]
6. XAF1 as a prognostic biomarker and therapeutic target in squamous cell lung cancer.
Chen YB; Shu J; Yang WT; Shi L; Guo XF; Wang FG; Qian YY
Chin Med J (Engl); 2011 Oct; 124(20):3238-43. PubMed ID: 22088514
[TBL] [Abstract][Full Text] [Related]
7. Restoration of XAF1 expression induces apoptosis and inhibits tumor growth in gastric cancer.
Tu SP; Liston P; Cui JT; Lin MC; Jiang XH; Yang Y; Gu Q; Jiang SH; Lum CT; Kung HF; Korneluk RG; Wong BC
Int J Cancer; 2009 Aug; 125(3):688-97. PubMed ID: 19358264
[TBL] [Abstract][Full Text] [Related]
8. Experimental study on inhibition effects of the XAF1 gene against lung cancer cell proliferation.
Yang WT; Chen DL; Zhang FQ; Xia YC; Zhu RY; Zhou DS; Chen YB
Asian Pac J Cancer Prev; 2014; 15(18):7825-9. PubMed ID: 25292071
[TBL] [Abstract][Full Text] [Related]
9. Expression of apoptosis-related proteins and its clinical implication in surgically resected gastric carcinoma.
Kim MA; Lee HE; Lee HS; Yang HK; Kim WH
Virchows Arch; 2011 Nov; 459(5):503-10. PubMed ID: 21947931
[TBL] [Abstract][Full Text] [Related]
10. Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer.
Wang Y; Mao H; Hao Q; Wang Y; Yang Y; Shen L; Huang S; Liu P
Regul Pept; 2012 Oct; 178(1-3):36-42. PubMed ID: 22759793
[TBL] [Abstract][Full Text] [Related]
11. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells.
Zhao WJ; Deng BY; Wang XM; Miao Y; Wang JN
Asian Pac J Cancer Prev; 2015; 16(6):2453-8. PubMed ID: 25824780
[TBL] [Abstract][Full Text] [Related]
12. Disturbed XIAP and XAF1 expression balance is an independent prognostic factor in gastric adenocarcinomas.
Shibata T; Noguchi T; Takeno S; Gabbert HE; Ramp U; Kawahara K
Ann Surg Oncol; 2008 Dec; 15(12):3579-87. PubMed ID: 18807090
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer.
Kempkensteffen C; Fritzsche FR; Johannsen M; Weikert S; Hinz S; Dietel M; Riener MO; Moch H; Jung K; Krause H; Miller K; Kristiansen G
BMC Cancer; 2009 Aug; 9():276. PubMed ID: 19664236
[TBL] [Abstract][Full Text] [Related]
14. XAF1 is frequently methylated in human esophageal cancer.
Chen XY; He QY; Guo MZ
World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
[TBL] [Abstract][Full Text] [Related]
15. [XAF1 inhibits cell proliferation and induces apoptosis in human lung adenocarcinoma cell line A549 in vitro].
Chen D; Zhang F; Sang Y; Zhu R; Zhang H; Chen Y
Zhongguo Fei Ai Za Zhi; 2014 Dec; 17(12):829-33. PubMed ID: 25539606
[TBL] [Abstract][Full Text] [Related]
16. Impact of X-linked inhibitor of apoptosis protein on survival of nasopharyngeal carcinoma patients following radiotherapy.
Ren M; Wang Z; Gao G; Gu X; Wu L; Chen L
Tumour Biol; 2016 Sep; 37(9):11825-11833. PubMed ID: 27048285
[TBL] [Abstract][Full Text] [Related]
17. Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions.
Shin CH; Lee MG; Han J; Jeong SI; Ryu BK; Chi SG
Proc Natl Acad Sci U S A; 2017 May; 114(22):5683-5688. PubMed ID: 28507149
[TBL] [Abstract][Full Text] [Related]
18. XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy.
Pinho MB; Costas F; Sellos J; Dienstmann R; Andrade PB; Herchenhorn D; Peixoto FA; Santos VO; Small IA; Guimarães DP; Ferreira CG
Urol Oncol; 2009; 27(4):382-90. PubMed ID: 18555708
[TBL] [Abstract][Full Text] [Related]
19. XAF1 mediates tumor necrosis factor-alpha-induced apoptosis and X-linked inhibitor of apoptosis cleavage by acting through the mitochondrial pathway.
Straszewski-Chavez SL; Visintin IP; Karassina N; Los G; Liston P; Halaban R; Fadiel A; Mor G
J Biol Chem; 2007 Apr; 282(17):13059-72. PubMed ID: 17329253
[TBL] [Abstract][Full Text] [Related]
20. Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin.
Ma B; Wang Y; Zhou X; Huang P; Zhang R; Liu T; Cui C; Liu X; Wang Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):419-29. PubMed ID: 25240826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
